Trial intelligence / Profile preview

Flumazenil for Remimazolam Reversal in Elderly Hip Surgery

NCT05939674Recruiting

Sponsor
Pusan National University Hospital
Start
Sep 2023
Primary completion
Feb 2026
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised trial of flumazenil in sedation (2 arms), sponsored by Pusan National University Hospital. Primary endpoints: Difference in eye opening time between the two groups and Difference in extubation time between the two groups. Started Sep 2023; status: recruiting.

02

Drugs

flumazenil
03

Conditions

sedation

Beyond the preview

Go deeper on NCT05939674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05939674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call